Certified by Founder Lodge
T. Rowe Price
United States - Baltimore, Maryland
INVESTOR
1 Disclosed Funding Rounds $223,000,000
64 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
T. Rowe Price is an asset management firm focused on delivering global investment management excellence and retirement services that investors can rely on—now, and over the long term.
Head
| Company | Date | Round | Raised |
|---|---|---|---|
 Tessera Therapeutics |
April, 19 ,2022 | Series C | $300,000,000 |
 Sortera Technologies, Inc. |
August, 31 ,2023 | Series C | $30,500,000 |
 Stash |
October, 16 ,2023 | Unknown | $40,000,000 |
 Cleerly |
July, 25 ,2022 | Series C | $223,000,000 |
 Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
 Flexe |
July, 07 ,2022 | Series D | $119,000,000 |
 Apiture |
November, 15 ,2023 | Unknown | $10,000,000 |
 Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
 KoBold Metals |
June, 21 ,2023 | Unknown | $195,000,000 |
 CARGO Therapeutics |
March, 06 ,2023 | Series A | $200,000,000 |
 RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Tessera Therapeutics |
April, 19 ,2022 | Series C | $300,000,000 |
 Odyssey Therapeutics |
December, 06 ,2023 | Series C | $101,000,000 |
| Stash |
October, 16 ,2023 | Unknown | $40,000,000 |
 Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
| Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
 Lambda |
February, 16 ,2024 | Series C | $320,000,000 |
| Apiture |
November, 15 ,2023 | Unknown | $10,000,000 |
| Sortera Technologies, Inc. |
August, 31 ,2023 | Series C | $30,500,000 |
| KoBold Metals |
June, 21 ,2023 | Unknown | $195,000,000 |
 Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Odyssey Therapeutics |
December, 06 ,2023 | Series C | $101,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
 Kardium Inc. |
June, 12 ,2024 | Unknown | $104,000,000 |
| Lambda |
February, 16 ,2024 | Series C | $320,000,000 |
| Stash |
October, 16 ,2023 | Unknown | $40,000,000 |
| Sortera Technologies, Inc. |
August, 31 ,2023 | Series C | $30,500,000 |
 Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| Apiture |
November, 15 ,2023 | Unknown | $10,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Odyssey Therapeutics |
December, 06 ,2023 | Series C | $101,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| Lambda |
February, 16 ,2024 | Series C | $320,000,000 |
| Kardium Inc. |
June, 12 ,2024 | Unknown | $104,000,000 |
| Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| Stash |
October, 16 ,2023 | Unknown | $40,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Kardium Inc. |
June, 12 ,2024 | Unknown | $104,000,000 |
| Apiture |
November, 15 ,2023 | Unknown | $10,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
 Form Energy |
October, 11 ,2024 | Series F | $405,000,000 |
| Odyssey Therapeutics |
December, 06 ,2023 | Series C | $101,000,000 |
 Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
| Lambda |
February, 16 ,2024 | Series C | $320,000,000 |
 Galvanize |
September, 04 ,2025 | Series C | $100,000,000 |
| Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Kardium Inc. |
June, 12 ,2024 | Unknown | $104,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Form Energy |
October, 11 ,2024 | Series F | $405,000,000 |
| Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
| Galvanize |
September, 04 ,2025 | Series C | $100,000,000 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
